US 12,144,522 B2
Devices for tissue treatment and methods of use thereof
Jonathan Shaw, Atlanta, GA (US); Brett Rogers, Atlanta, GA (US); Shawna Hagen, Atlanta, GA (US); Luka Grujic, Boston, MA (US); and Kenneth R. Mautner, Atlanta, GA (US)
Assigned to TendoNova Corporation, Atlanta, GA (US)
Appl. No. 17/045,298
Filed by TendoNova Corporation, Atlanta, GA (US)
PCT Filed Apr. 2, 2019, PCT No. PCT/US2019/025297
§ 371(c)(1), (2) Date Oct. 5, 2020,
PCT Pub. No. WO2019/195221, PCT Pub. Date Oct. 10, 2019.
Claims priority of provisional application 62/653,712, filed on Apr. 6, 2018.
Prior Publication US 2021/0145477 A1, May 20, 2021
Int. Cl. A61B 17/34 (2006.01); A61B 90/00 (2016.01); A61B 17/00 (2006.01)
CPC A61B 17/3476 (2013.01) [A61B 17/3403 (2013.01); A61B 90/06 (2016.02); A61B 2017/00026 (2013.01); A61B 2017/00075 (2013.01); A61B 2017/00876 (2013.01); A61B 2017/3413 (2013.01); A61B 2090/064 (2016.02)] 8 Claims
OG exemplary drawing
 
1. A tissue penetrating device, the device comprising:
a first portion housing a motor; and
a second portion housing at least a distal portion of a tissue penetrating element, wherein the tissue penetrating element is operably coupled to the motor via a magnetic coupling, which coupling resides on a single side of a sterile field,
wherein the magnetic coupling comprises an attachment member housed within the second portion; and
wherein the attachment member comprises a housing including a closed proximal end and an open distal end and a length defined therebetween, wherein an edge of the open distal end is sealed into engagement with an interior of the second portion, thereby isolating an interior of the housing from a remainder of the first and second portions of the tissue penetrating device, and thereby creating the sterile field external of the attachment member.